KEY POINTSJohnson & Johnson reported double-digit sales and earnings growth in 2021.The healthcare stock has a spectacular balance sheet and low dividend payout ratio.Johnson & Johnson is priced at a ...
Source LinkKEY POINTSJohnson & Johnson reported double-digit sales and earnings growth in 2021.The healthcare stock has a spectacular balance sheet and low dividend payout ratio.Johnson & Johnson is priced at a ...
Source Link
Comments